Skip to main content

Table 7 Medical and social consequences of headache

From: Primary headaches in patients with generalized anxiety disorder

Variable

GAD

Controls

P

MIDAS score, mean ± SD (range)

29.1 ± 68.4 (0–260)

2.1 ± 0.2 (0–3)

0.019**

Use of healthcare services, mean ± SD (range)

12.5 ± 8.1 (0–33)

2.4 ± 2.6 (0–9)

<0.001**

SF-36 functional capacity domain, mean ± SD (total n)

65.3 ± 25.1 (n = 29)

95.8 ± 5.6 (n = 30)

<0.001**

SF-36 physical function domain, mean ± SD (total n)

49.1 ± 41.4 (n = 29)

97.5 ± 7.6 (n = 30)

<0.001**

SF-36 bodily pain domain, mean ± SD (total n)

64.1 ± 20.7 (n = 29)

88.8 ± 18.8 (n = 30)

<0.001**

SF-36 general health domain, mean ± SD (total n)

72.1 ± 21.2 (n = 29)

92.4 ± 10.6 (n = 30)

<0.001**

SF-36 vitality domain, mean ± SD (total n)

43.4 ± 21.7 (n = 29)

82.0 ± 13.6 (n = 30)

<0.001**

SF-36 social function domain, mean ± SD (total n)

56.0 ± 31.1 (n = 29)

96.7 ± 7.9 (n = 30)

<0.001**

SF-36 emotional function domain, mean ± SD (total n)

44.8 ± 44.8 (n = 29)

97.8 ± 12.2 (n = 30)

<0.001**

SF-36 mental health domain, mean ± SD (total n)

42.2 ± 22.5 (n = 29)

85.2 ± 14.1 (n = 30)

<0.001**

  1. GAD generalized anxiety disorder (patients), MIDAS migraine disability assessment, SF-36 36-item short-form health survey
  2. * Mann–Whitney test